STEPS-EA trial: the first ERNICA RCT!

Posted on 01 October 2019

The STEPS-EA trial is a multi-centre Randomised Controlled Trial looking at intralesional STEroid injections to Prevent refractory Strictures in patients with Esophageal Atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection. 

This is the first ERNICA randomized controlled trial and the trial team is excited to announce that they are now waiting for the first eligible patient to include. 

Click here for the first STEPS-EA trial newsletter which provides an update on progress so far!

For any questions please email the The STEPS-EA trial team at